跳至主要内容
临床试验/JPRN-UMIN000024392
JPRN-UMIN000024392已完成未知

Glutamate and Antipsychotic Treatment Response in Patients with Schizophrenia: a Cross-Sectional Multimodal MRI Study - Glutamate and Antipsychotic Treatment Response in Patients with Schizophrenia

Keio University School of Medicine Department of Neuropsychiatry0 个研究点目标入组 95 人开始时间: 2016年10月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
95

研究概览

简要总结

A total of 95 participants were included (TRS=29, non-TRS=33, and HCs=33). dACCGlx levels were higher in the TRS group versus HCs. No group differences were identified in the caudate. Our results suggest that higher Glx levels in the dACC may reflect the difference indisease category between TRS and non-TRS.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Not translated yet

研究者

发起方
Keio University School of Medicine Department of Neuropsychiatry

相似试验